#United States #Dallas #Perimeter Medical #Medical City Dallas #OCT imaging

Medical City Dallas Hospital Integrates Perimeter's Advanced Imaging Tech

Medical City Dallas Hospital, a distinguished acute care facility in the Dallas-Fort Worth region, has recently incorporated Perimeter Medical Imaging AI's innovative S-Series Optical Coherence Tomography (OCT) technology into its surgical offerings. This decision follows the hospital's involvement in a pivotal clinical trial evaluating Perimeter's next-generation B-Series device, which pairs cutting-edge artificial intelligence (AI) capabilities with OCT for breast-conserving surgeries.

Perimeter Medical Imaging AI Inc. (TSXV: PINK, OTCQX: PYNKF), a company dedicated to revolutionizing cancer surgery through state-of-the-art imaging solutions, is thrilled to see its technology being utilized in this prominent medical institution. Adrian Mendes, Perimeter's CEO, emphasized their pride in collaborating with an innovative team of surgeons at Medical City Dallas, explaining how the clinical trials have been instrumental in refining their next-generation product. The integration of the S-Series OCT technology aims to enhance the visualization of tissue microstructures, thereby facilitating informed surgical decisions in real-time.

What is S-Series OCT Technology?

The S-Series OCT represents a significant advancement over traditional imaging methodologies like X-rays or MRIs. Unlike these conventional methods, which sometimes can overlook crucial disease indicators, this high-resolution OCT technology provides detailed cellular-level imagery. Specifically optimized to identify areas of interest within tissue microstructures, it can showcase vital features such as blood vessels and glands. With its capability to see as fine as 2mm, the technology plays a crucial role in assisting surgeons to visualize surgical margins accurately.

FDA cleared in 2021 for general tissue use, the S-Series OCT is now being rapidly deployed across several medical facilities in the United States, solidifying its role as a leading imaging tool in surgeries.

The Impact on Surgical Practices

The implications of adopting Perimeter's technology are profound, particularly in the realm of cancer surgeries where precision is paramount. As previously noted, the surgery leadership team at Medical City Dallas has already shown promising results while utilizing the B-Series device in clinical trials, which are under evaluation by the U.S. Food and Drug Administration for broader use. The potential to significantly reduce margin-related complications and improve surgical outcomes aligns closely with Perimeter's mission to address significant unmet medical needs in cancer surgery.

Future Prospects and Developments

Perimeter Medical Imaging AI has ambitious plans for further innovations in this domain. The investigational B-Series OCT device, in conjunction with ImgAssist AI, demonstrates the company's commitment to harnessing AI technologies and enhancing imaging procedures overall. Funded by substantial grants, including up to $7.4 million from the Cancer Prevention and Research Institute of Texas, Perimeter continues to push the boundaries of medical imaging.

Conclusion

The collaboration between Perimeter Medical Imaging AI and Medical City Dallas Hospital marks a pivotal moment for cancer surgery. By leveraging advanced imaging technologies, these institutions reaffirm their commitment to improving patient care and surgical success rates. As we look ahead, developments in OCT imaging combined with AI promise to revolutionize how surgical teams visualize and treat cancer, ultimately leading to better outcomes for patients nationwide.

To learn more about Perimeter Medical Imaging and their groundbreaking work, please visit www.perimetermed.com.